Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNV-166 SAD and MAD Study in Healthy Male Volunteers
NCT07809360Phase 1Completed
- Sponsor
- InVitro Research Solutions
- Start
- Aug 2024
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of RNV-166 (9 arms), sponsored by InVitro Research Solutions. Primary endpoints: Treatment Emergent Adverse Events, Evaluations of clinical laboratory and changes from baseline and 9 more. Started Aug 2024; status: completed.
02
Drugs
RNV-166
Beyond the preview
Go deeper on NCT07809360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07809360.